vs
Side-by-side financial comparison of SciSparc Ltd. (SPRC) and TaoWeave, Inc. (TWAV). Click either name above to swap in a different company.
TaoWeave, Inc. is the larger business by last-quarter revenue ($622.0K vs $461.0K, roughly 1.3× SciSparc Ltd.). TaoWeave, Inc. runs the higher net margin — -448.2% vs -2041.6%, a 1593.4% gap on every dollar of revenue. On growth, TaoWeave, Inc. posted the faster year-over-year revenue change (10.5% vs -45.1%).
SciSparc Ltd. is a clinical-stage biopharmaceutical company focused on developing novel therapies for unmet medical needs in the neurological, psychiatric, and gastrointestinal disorder segments. It operates across global biotech markets, leveraging proprietary cannabinoid-based formulation technologies to advance its pipeline of therapeutic candidates.
SPRC vs TWAV — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $461.0K | $622.0K |
| Net Profit | $-9.4M | $-2.8M |
| Gross Margin | 78.1% | 47.1% |
| Operating Margin | -588.5% | -126.4% |
| Net Margin | -2041.6% | -448.2% |
| Revenue YoY | -45.1% | 10.5% |
| Net Profit YoY | -155.8% | -215.4% |
| EPS (diluted) | $17.92 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $622.0K | ||
| Q3 25 | — | $601.0K | ||
| Q2 25 | $461.0K | $592.0K | ||
| Q1 25 | — | $622.0K | ||
| Q4 24 | $466.0K | $563.0K | ||
| Q3 24 | — | $578.0K | ||
| Q2 24 | $840.0K | $611.0K | ||
| Q1 24 | — | $626.0K |
| Q4 25 | — | $-2.8M | ||
| Q3 25 | — | $-2.3M | ||
| Q2 25 | $-9.4M | $-605.0K | ||
| Q1 25 | — | $-672.0K | ||
| Q4 24 | $-3.8M | $-884.0K | ||
| Q3 24 | — | $-1.0M | ||
| Q2 24 | $-3.7M | $-983.0K | ||
| Q1 24 | — | $-1.1M |
| Q4 25 | — | 47.1% | ||
| Q3 25 | — | 40.6% | ||
| Q2 25 | 78.1% | 38.5% | ||
| Q1 25 | — | 40.0% | ||
| Q4 24 | 6.9% | 24.0% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | 56.4% | 19.6% | ||
| Q1 24 | — | -0.5% |
| Q4 25 | — | -126.4% | ||
| Q3 25 | — | -133.4% | ||
| Q2 25 | -588.5% | -115.4% | ||
| Q1 25 | — | -111.1% | ||
| Q4 24 | -813.1% | -164.8% | ||
| Q3 24 | — | -185.5% | ||
| Q2 24 | -419.9% | -166.6% | ||
| Q1 24 | — | -189.1% |
| Q4 25 | — | -448.2% | ||
| Q3 25 | — | -381.0% | ||
| Q2 25 | -2041.6% | -102.2% | ||
| Q1 25 | — | -108.0% | ||
| Q4 24 | -813.9% | -157.0% | ||
| Q3 24 | — | -179.9% | ||
| Q2 24 | -438.0% | -160.9% | ||
| Q1 24 | — | -181.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $17.92 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-8.82 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $35.70 | — | ||
| Q1 24 | — | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $2.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-81.0K | $7.0M |
| Total Assets | $5.1M | $8.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $3.7M | ||
| Q2 25 | $1.5M | $10.8M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | $1.5M | $5.0M | ||
| Q3 24 | — | $5.6M | ||
| Q2 24 | $252.0K | $5.9M | ||
| Q1 24 | — | — |
| Q4 25 | — | $7.0M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | $-81.0K | $11.3M | ||
| Q1 25 | — | $3.4M | ||
| Q4 24 | $8.9M | $4.0M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | $8.7M | $5.1M | ||
| Q1 24 | — | $4.4M |
| Q4 25 | — | $8.2M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | $5.1M | $13.1M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | $10.3M | $5.3M | ||
| Q3 24 | — | $6.0M | ||
| Q2 24 | $10.5M | $6.3M | ||
| Q1 24 | — | $5.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.9M | $-744.0K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-744.0K | ||
| Q3 25 | — | $-1.6M | ||
| Q2 25 | $-1.9M | $-37.0K | ||
| Q1 25 | — | $-680.0K | ||
| Q4 24 | $-2.9M | $-255.0K | ||
| Q3 24 | — | $-911.0K | ||
| Q2 24 | $-2.2M | $-1.6M | ||
| Q1 24 | — | $-630.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-2.2M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -261.7% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
